Učitavanje...
Development of a copper-clioquinol formulation suitable for intravenous use
Clioquinol (CQ) is an FDA-approved topical antifungal agent known to kill cancer cells. This facilitated the initiation of clinical trials in patients with refractory hematologic malignancies. These repurposing efforts were not successful; this was likely due to low intracellular levels of the drug...
Spremljeno u:
| Izdano u: | Drug Deliv Transl Res |
|---|---|
| Glavni autori: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer US
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5756275/ https://ncbi.nlm.nih.gov/pubmed/29247315 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13346-017-0455-7 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|